Medicare Enrolled
Dr. Neelantha De Silva, M.D.
Neurology · Fort Myers, FL
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Silva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Silva? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. De Silva
Dr. Neelantha De Silva is a neurology in Fort Myers, FL, with 19 years in practice. Based on federal Medicare data, Dr. De Silva performed 2,353 Medicare services across 1,018 unique beneficiaries.
Between the years covered by Open Payments, Dr. De Silva received a total of $29,904 from 83 pharmaceutical and/or device companies across 1211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De Silva is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 18% volume in FL$ $29,904 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,353
Medicare services
Top 18% in FL for neurology
1,018
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~124 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 1,116 | $27 | $75 |
| Office visit, established patient (30-39 min) | 432 | $98 | $150 |
| Hospital follow-up visit, high complexity | 118 | $99 | $154 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 113 | $38 | $397 |
| New patient office visit (45-59 min) | 105 | $136 | $400 |
| Needle measurement of electrical activity in arm or leg muscles, 2 extremities | 99 | $68 | $400 |
| Initial hospital admission, high complexity | 84 | $145 | $350 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 61 | $99 | $400 |
| Ultrasound of both sides of head and neck blood flow | 58 | $32 | $100 |
| EEG, extended monitoring | 33 | $47 | $210 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 26 | $32 | $200 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 16 | $88 | $200 |
| Nerve conduction, 13 or more studies | 15 | $248 | $850 |
| Evaluation and testing for balance with recording | 13 | $90 | $185 |
| Test for abnormal eye movement using a rotating chair | 13 | $118 | $190 |
| Use of electrodes during balance testing | 13 | $10 | $35 |
| Test to assess electrical potentials generated in the inner ear as a result of sound stimulation | 13 | $102 | $195 |
| Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | 13 | $75 | $160 |
| Vemp testing of lower branch of inner ear nerve with interpretation and report | 12 | $63 | $145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,904
Total received (2018-2024)
Avg $4,272/year across 7 years
Top 12% in FL for neurology
83
Companies
1,211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,106 (84.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,799 (16.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,039
2023$4,703
2022$4,483
2021$2,090
2020$1,360
2019$4,144
2018$8,086
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$5,171
Biogen, Inc.
$2,504
UCB, Inc.
$1,716
Novartis Pharmaceuticals Corporation
$1,646
SK Life Science, Inc.
$1,189
EMD Serono, Inc.
$1,092
Lundbeck LLC
$1,082
ABBVIE INC.
$997
AbbVie Inc.
$980
Alexion Pharmaceuticals, Inc.
$889
Supernus Pharmaceuticals, Inc.
$887
Amgen Inc.
$700
Neurocrine Biosciences, Inc.
$591
GENZYME CORPORATION
$566
PFIZER INC.
$546
Lilly USA, LLC
$513
Grifols USA, LLC
$483
Ipsen Biopharmaceuticals, Inc
$468
Jazz Pharmaceuticals Inc.
$452
Eisai Inc.
$395
ARGENX US, INC.
$387
Amneal Pharmaceuticals LLC
$378
Allergan Inc.
$336
ACADIA Pharmaceuticals Inc
$313
Avanir Pharmaceuticals, Inc.
$306
Celgene Corporation
$305
Genentech USA, Inc.
$305
MDD US Operations, LLC
$288
Biohaven Pharmaceutical Holding Company Ltd.
$283
NOVARTIS PHARMACEUTICALS CORPORATION
$255
Takeda Pharmaceuticals U.S.A., Inc.
$250
EISAI INC.
$220
TG Therapeutics, Inc.
$206
Kyowa Kirin, Inc.
$195
Greenwich Biosciences, Inc.
$193
Forte Bio-Pharma LLC
$139
Medtronic, Inc.
$136
Banner Life Sciences, LLC
$135
CSL Behring
$120
Janssen Pharmaceuticals, Inc
$120
Acorda Therapeutics, Inc
$120
Adamas Pharmaceuticals, Inc.
$107
Allergan, Inc.
$102
Neurelis, Inc.
$101
Abbott Laboratories
$88
TG THERAPEUTICS, INC.
$88
Otsuka America Pharmaceutical, Inc.
$87
Mallinckrodt Enterprises LLC
$84
MITSUBISHI TANABE PHARMA AMERICA, INC.
$81
Impax Laboratories, Inc.
$75
Merz North America, Inc.
$75
LivaNova USA, Inc.
$73
Amylyx Pharmaceuticals, Inc.
$66
Vertical Pharmaceuticals, LLC
$64
Octapharma USA, Inc.
$64
BANNER LIFE SCIENCES, LLC
$63
US WorldMeds, LLC
$56
SCILEX PHARMACEUTICALS INC.
$54
Mallinckrodt Hospital Products Inc.
$51
CATALYST PHARMACEUTICALS, INC.
$48
AstraZeneca Pharmaceuticals LP
$47
Corium, LLC
$46
JAZZ PHARMACEUTICALS INC.
$42
Merz Pharmaceuticals, LLC
$38
NEUROPACE, INC.
$38
AbbVie, Inc.
$34
HARMONY BIOSCIENCES LLC
$33
Mitsubishi Tanabe Pharma America, Inc.
$32
Biohaven Pharmaceuticals, Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$29
UPSHER-SMITH LABORATORIES LLC
$29
Alnylam Pharmaceuticals Inc.
$27
GE HealthCare
$26
Catalyst Pharmaceuticals, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$22
Mylan Pharmaceuticals Inc.
$18
ASSERTIO THERAPEUTICS, Inc.
$18
Akcea Therapeutics, Inc.
$17
Scilex Pharmaceuticals Inc.
$15
ASSERTIO THERAPEUTICS, INC.
$15
Assertio Therapeutics, Inc.
$14
BOSTON SCIENTIFIC CORPORATION
$12
Almatica Pharma LLC
$11
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CLOSUREFAST · COMIRNATY · COPAXONE · Cambia · DAYBUE · DISEASE STATE · DIVIGEL · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · EVUSHELD · Enspryng · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalocet · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · OXTELLAR XR · Ocrevus · PANZYGA · PAXLOVID · PIPELINE-MS · PLEGRIDY · Ponvory · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUNOSI · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XARELTO · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1,271 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
182
Per 100K population
23.0
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. De Silva is a remote monitoring specialist, with above-average Medicare volume (top 18% in FL), and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. De Silva experienced with continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)?
Based on Medicare claims data, Dr. De Silva performed 1,116 continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De Silva receive payments from pharmaceutical companies?
Yes. Dr. De Silva received a total of $29,904 from 83 companies across 1,211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Silva's costs compare to other neurologys in Fort Myers?
Dr. De Silva's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Silva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Fort Myers
Browse neurologys in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc..
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology